Synaptic Cell Adhesion Molecules in Alzheimer's Disease

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Leshchyns'Ka, Iryna ^a   Sytnyk, Vladimir ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CELL ADHESION MOLECULE; SYNAPTIC CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BIOCHEMICAL ANALYSIS; BRAIN TISSUE; CELL ADHESION; CEREBROSPINAL FLUID; GENETIC ASSOCIATION; HUMAN; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SYNAPTIC MEMBRANE; ANIMAL; BRAIN; METABOLISM; NERVE CELL; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CELL ADHESION MOLECULES; HUMANS; NEURONS; SYNAPSES;

EID: 84971222479     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2016/6427537     Document Type: Review

References (95)

1. L. Shapiro, J. Love, and D. R. Colman, "Adhesion molecules in the nervous system: structural insights into function and diversity, " Annual Review of Neuroscience, vol. 30, pp. 451-474, 2007.
2. V. Sytnyk, I. Leshchyns'ka, M. Delling, G. Dityateva, A. Dityatev, and M. Schachner, "Neural cell adhesion molecule promotes accumulation of TGN organelles at sites of neuron-to-neuron contacts, " Journal of Cell Biology, vol. 159, no. 4, pp. 649-661, 2002.
3. A. Dityatev, G. Dityateva, V. Sytnyk et al., "Polysialylated neural cell adhesion molecule promotes remodeling and formation of hippocampal synapses, " The Journal of Neuroscience, vol. 24, no. 42, pp. 9372-9382, 2004.
4. A. Shetty, V. Sytnyk, I. Leshchyns'ka, D. Puchkov, V. Haucke, and M. Schachner, "The neural cell adhesion molecule promotes maturation of the presynaptic endocytotic machinery by switching synaptic vesicle recycling from adaptor protein 3 (AP-3)-to AP-2-dependent mechanisms, " The Journal of Neuroscience, vol. 33, no. 42, pp. 16828-16845, 2013.
5. D. Puchkov, I. Leshchyns'ka, A. G. Nikonenko, M. Schachner, and V. Sytnyk, "NCAM/spectrin complex disassembly results in PSD perforation and postsynaptic endocytic zone formation, " Cerebral Cortex, vol. 21, no. 10, pp. 2217-2232, 2011.
6. P. Mendez, M. De Roo, L. Poglia, P. Klauser, and D. Muller, "Ncadherin mediates plasticity-induced long-termspine stabilization, " The Journal of Cell Biology, vol. 189, no. 3, pp. 589-600, 2010.
7. D. L. Benson andG. W. Huntley, "Synapse adhesion: A dynamic equilibriumconferring stability and flexibility, " CurrentOpinion in Neurobiology, vol. 22, no. 3, pp. 397-404, 2012.
8. A. Andreyeva, I. Leshchyns'ka, M. Knepper et al., "CHL1 is a selective organizer of the presynaptic machinery chaperoning the SNARE complex, " PLoS ONE, vol. 5, no. 8, Article IDe12018, 2010.
9. I. Leshchyns'ka, V. Sytnyk, M. Richter, A. Andreyeva, D. Puchkov, and M. Schachner, "Theadhesionmolecule CHL1 regulates uncoating of clathrin-coated synaptic vesicles, " Neuron, vol. 52, no. 6, pp. 1011-1025, 2006.
10. V. Sytnyk, I. Leshchyns'Ka, A. G. Nikonenko, and M. Schachner, "NCAM promotes assembly and activity-dependent remodeling of the postsynaptic signaling complex, " Journal of Cell Biology, vol. 174, no. 7, pp. 1071-1085, 2006.
11. M. Schachner, "Neural recognition molecules and synaptic plasticity, " Current Opinion in Cell Biology, vol. 9, no. 5, pp. 627-634, 1997.
12. K. Gerrow and A. El-Husseini, "Cell adhesion molecules at the synapse, " Frontiers in Bioscience, vol. 11, no. 2, pp. 2400-2419, 2006.
13. T. C. Südhof, "Neuroligins and neurexins link synaptic function to cognitive disease, " Nature, vol. 455, no. 7215, pp. 903-911, 2008.
14. E. Seong, L. Yuan, and J. Arikkath, "Cadherins and catenins in dendrite and synapse morphogenesis, " Cell Adhesion & Migration, vol. 9, no. 3, pp. 202-213, 2015.
15. X. Yang, D. Hou, W. Jiang, and C. Zhang, "Intercellular proteinprotein interactions at synapses, " Protein and Cell, vol. 5, no. 6, pp. 420-444, 2014.
16. S. W. Scheff and D. A. Price, "Synaptic pathology in Alzheimer's disease: A review of ultrastructural studies, " Neurobiology of Aging, vol. 24, no. 8, pp. 1029-1046, 2003.
17. K. C. Wilcox, P. N. Lacor, J. Pitt, and W. L. Klein, "A oligomerinduced synapse degeneration in Alzheimer's disease, " Cellular and molecular neurobiology, vol. 31, no. 6, pp. 939-948, 2011.
18. P. N. Lacor, M. C. Buniel, P. W. Furlow et al., "A oligomerinduced aberrations in synapse composition, shape, and density provide amolecular basis for loss of connectivity in Alzheimer's disease, " The Journal of Neuroscience, vol. 27, no. 4, pp. 796-807, 2007.
19. E. Pham, L. Crews, K. Ubhi et al., "Progressive accumulation of amyloid oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins, " FEBS Journal, vol. 277, no. 14, pp. 3051-3067, 2010.
20. M. Klevanski, U. Herrmann, S. W. Weyer et al., "The APP intracellular domain is required for normal synaptic morphology, synaptic plasticity, and hippocampus-dependent behavior, " Journal of Neuroscience, vol. 35, no. 49, pp. 16018-16033, 2015.
21. M. Lassek, J. Weingarten, M. Wegner, and W. Volknandt, "The amyloid precursor protein-a novel player within the molecular array of presynaptic nanomachines, " Frontiers in Synaptic Neuroscience, vol. 7, article 21, 2015.
22. H. S. Nhan, K. Chiang, and E. H. Koo, "Themultifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes, " Acta Neuropathologica, vol. 129, no. 1, pp. 1-19, 2015.
23. M. Nicolas and B. A. Hassan, "Amyloid precursor protein and neural development, " Development, vol. 141, no. 13, pp. 2543-2548, 2014.
24. X. Bao, G. Liu, Y. Jiang et al., "Cell adhesion molecule pathway genes are regulated by cis-regulatory SNPs and show significantly altered expression in Alzheimer's disease brains, " Neurobiology of Aging, vol. 36, no. 10, pp. 2904-2904. e7, 2015.
25. L. Bertram, M. B. McQueen, K. Mullin, D. Blacker, and R. E. Tanzi, "Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database, " Nature Genetics, vol. 39, no. 1, pp. 17-23, 2007.
26. R. Del Bo, M. Scarlato, S. Ghezzi et al., "IsM129V of PRNP gene associated with Alzheimer's disease A case-control study and a meta-analysis, " Neurobiology of Aging, vol. 27, no. 5, pp. 770. e1-770. e5, 2006.
27. B. Dermaut, E. A. Croes, R. Rademakers et al., "PRNP Val129 homozygosity increases risk for early-onset Alzheimer's disease, " Annals of Neurology, vol. 53, no. 3, pp. 409-412, 2003.
28. M. Riemenschneider, N. Klopp, W. Xiang et al., "Prion protein codon 129 polymorphism and risk of Alzheimer disease, " Neurology, vol. 63, no. 2, pp. 364-366, 2004.
29. R. Kimura, K. Kamino, M. Yamamotoet al., "TheDYRK1Agene, encoded in chromosome 21 Down syndrome critical region, bridges between amyloid production and tau phosphorylation in Alzheimer disease, " Human Molecular Genetics, vol. 16, no. 1, pp. 15-23, 2007.
30. M. R. Han, G. D. Schellenberg, and L. S. Wang, "Genome-wide association reveals genetic effects on human Abeta42 and tau protein levels in cerebrospinal fluids: A case control study, " BMC Neurology, vol. 10, article 90, 2010.
31. Y. Shimoda, F. Koseki, M. Itoh, M. Toyoshima, and K. Watanabe, "A cis-complex of NB-2/contactin-5 with amyloid precursorlike protein 1 is localized on the presynaptic membrane, " Neuroscience Letters, vol. 510, no. 2, pp. 148-153, 2012.
32. D. Harold, R. Abraham, P. Hollingworth et al., "Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, " Nature Genetics, vol. 41, no. 10, pp. 1088-1093, 2009.
33. M. Khondoker, S. Newhouse, E. Westman et al., "Linking genetics of brain changes to Alzheimer's disease: sparse whole genome association scan of regional MRI volumes in the ADNI andAddNeuroMed cohorts, " Journal of Alzheimer's Disease, vol. 45, no. 3, pp. 851-864, 2015.
34. I.-J. Kim, Y. Zhang, M. Yamagata, M. Meister, and J. R. Sanes, "Molecular identification of a retinal cell type that responds to upward motion, " Nature, vol. 452, no. 7186, pp. 478-482, 2008.
35. A. Antonell, E. Gelpi, R. Sánchez-Valle, R. Martínez, J. L. Molinuevo, and A. Lladó, "Breakpoint sequence analysis of an APP locus duplication associated with autosomal dominant Alzheimer's disease and severe cerebral amyloid angiopathy, " Journal of Alzheimer's Disease, vol. 28, no. 2, pp. 303-308, 2012.
36. E. R. Martin, P. G. Bronson, Y.-J. Li et al., "Interaction between the T catenin gene (VR22) and APOE in Alzheimer's disease, " Journal of Medical Genetics, vol. 42, no. 10, pp. 787-792, 2005.
37. A. Martinez-Mir, A. González-Pérez, J. Gayán et al., "Genetic study of neurexin and neuroligin genes in Alzheimer's disease, " Journal of Alzheimer's Disease, vol. 35, no. 2, pp. 403-412, 2013.
38. O. S. Jørgensen, B. W. Brooksbank, and R. Balázs, "Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer disease, " Journal of the Neurological Sciences, vol. 98, no. 1, pp. 63-79, 1990.
39. D. T. Yew, W. P. Li, S. E. Webb, H. W. L. Lai, and L. Zhang, "Neurotransmitters, peptides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: A comparison, " Experimental Gerontology, vol. 34, no. 1, pp. 117-133, 1999.
40. B. Aisa, F. J. Gil-Bea, M. Solas et al., "Altered NCAM expression associated with the cholinergic system in Alzheimer's disease, " Journal of Alzheimer's Disease, vol. 20, no. 2, pp. 659-668, 2010.
41. A. M. Gillian, J. P. Brion, and K. C. Breen, "Expression of the neural cell adhesion molecule (NCAM) in Alzheimer's disease, " Neurodegeneration, vol. 3, no. 4, pp. 283-291, 1994.
42. M. Mikkonen, H. Soininen, T. Tapiola, I. Alafuzoff, and R. Miettinen, "Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation, " European Journal of Neuroscience, vol. 11, no. 5, pp. 1754-1764, 1999.
43. R. L. Schnaar, R. Gerardy-Schahn, and H. Hildebrandt, "Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration, " Physiological Reviews, vol. 94, no. 2, pp. 461-518, 2014.
44. V. Gautam, C. D'Avanzo, M. Hebisch, D. M. Kovacs, and D. Y. Kim, "BACE1 activity regulates cell surface contactin-2 levels, " Molecular Neurodegeneration, vol. 9, no. 1, article 4, 2014.
45. H. Fukumoto, B. S. Cheung, B. T. Hyman, and M. C. Irizarry, " Secretase protein and activity are increased in the neocortex in Alzheimer disease, " Archives of Neurology, vol. 59, no. 9, pp. 1381-1389, 2002.
46. S. J. Tyler, D. Dawbarn, G. K. Wilcock, and S. J. Allen, " and secretase: profound changes in Alzheimer's disease, " Biochemical and Biophysical Research Communications, vol. 299, no. 3, pp. 373-376, 2002.
47. L.-B. Yang, K. Lindholm, R. Yan et al., "Elevated secretase expression and enzymatic activity detected in sporadic Alzheimer disease, " Nature Medicine, vol. 9, no. 1, pp. 3-4, 2003.
48. J. S. Miners, Z. Van Helmond, P. G. Kehoe, and S. Love, "Changes with age in the activities of secretase and the a degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme, " Brain Pathology, vol. 20, no. 4, pp. 794-802, 2010.
49. R. Li, K. Lindholm, L. Yang et al., "Amyloid peptide load is correlated with increased secretase activity in sporadic Alzheimer's disease patients, " Proceedings of the National Academy of Sciences, vol. 101, no. 10, pp. 3632-3637, 2004.
50. L. Zhou, S. Barão, M. Laga et al., "The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo, " The Journal of Biological Chemistry, vol. 287, no. 31, pp. 25927-25940, 2012.
51. B. Hitt, S. M. Riordan, L. Kukreja, W. A. Eimer, T. W. Rajapaksha, and R. Vassar, " Site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects, " The Journal of Biological Chemistry, vol. 287, no. 46, pp. 38408-38425, 2012.
52. S. Riedle, H. Kiefel, D. Gast et al., "Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/ secretase activity, " Biochemical Journal, vol. 420, no. 3, pp. 391-402, 2009.
53. D. Lutz, G. Wolters-Eisfeld, G. Joshi et al., "Generation and nuclear translocation of sumoylated transmembrane fragment of cell adhesion molecule L1, "The Journal of Biological Chemistry, vol. 287, no. 21, pp. 17161-17175, 2012.
54. I. J. Whitehouse, C. Jackson, A. J. Turner, and N. M. Hooper, "Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease, " Journal of Alzheimer's Disease, vol. 22, no. 3, pp. 1023-1031, 2010.
55. I. J. Whitehouse, J. S. Miners, E. B. C. Glennon et al., "Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid levels and Braak stage, " PLoS ONE, vol. 8, no. 4, Article ID e59554, 2013.
56. K. Ando, K. Uemura, A. Kuzuya et al., "N-cadherin regulates p38 MAPK signaling via association with JNK-associated leucine zipper protein: implications for neurodegeneration in Alzheimer disease, "The Journal of Biological Chemistry, vol. 286, no. 9, pp. 7619-7628, 2011.
57. A. Andreyeva, K. Nieweg, K. Horstmann et al., "C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid, " Brain, vol. 135, no. 7, pp. 2140-2154, 2012.
58. F. X. Lepelletier, D. M. Mann, A. C. Robinson, E. Pinteaux, and H. Boutin, "Early changes in extracellular matrix in Alzheimer's disease, " Neuropathology and Applied Neurobiology, 2015.
59. I. Leshchyns'ka, H. T. Liew, C. Shepherd et al., "A Dependent reduction of NCAM2-mediated synaptic adhesion contributes to synapse loss inAlzheimer's disease, "Nature Communications, vol. 6, article 8836, 2015.
60. H. Strekalova, C. Buhmann, R. Kleene et al., "Elevated levels of neural recognition molecule L1 in the cerebrospinal fluid of patients with Alzheimer disease and other dementia syndromes, " Neurobiology of Aging, vol. 27, no. 1, pp. 1-9, 2006.
61. L. Todaro, L. Puricelli, H. Gioseffi et al., "Neural cell adhesion molecule in human serum. Increased levels in dementia of the Alzheimer type, " Neurobiology of Disease, vol. 15, no. 2, pp. 387-393, 2004.
62. M. Müller, J. A. Claassen, H. B. Kuiperij, and M. M. Verbeek, "Cerebrospinal fluid NrCAM is not a suitable biomarker to discriminate between dementia disorders-a pilot study, " Journal of Alzheimer's Disease, vol. 46, no. 3, pp. 605-609, 2015.
63. M. Poltorak, J. J. Hemperly, J. R. Williams, R. El-Mallakh, and W. J. Freed, "Disturbances in cell recognition molecules (N-CAM and L1 antigen) in the CSF of patients with schizophrenia, " Experimental Neurology, vol. 131, no. 2, pp. 266-272, 1995.
64. M. Poltorak, M. A. Frye, R. Wright et al., "Increased neural cell adhesion molecule in the CSF of patients with mood disorder, " Journal of Neurochemistry, vol. 66, no. 4, pp. 1532-1538, 1996.
65. A. E. Purcell, M. M. Rocco, J. A. Lenhart, K. Hyder, A. W. Zimmerman, and J. Pevsner, "Assessment of neural cell adhesion molecule (NCAM) in autistic serumand postmortem brain, " Journal of Autism and Developmental Disorders, vol. 31, no. 2, pp. 183-194, 2001.
66. N. Djogo, I. Jakovcevski, C. Müller et al., "Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice, " Neurobiology of Disease, vol. 56, pp. 104-115, 2013.
67. S. Chen, S. P. Yadav, and W. K. Surewicz, "Interaction between human prion protein and amyloid (A) oligomers: role of Nterminal residues, " The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26377-26383, 2010.
68. W.-Q. Zou, X. Xiao, J. Yuan et al., "Amyloid 42 interacts mainly with insoluble prion protein in the Alzheimer brain, "The Journal of Biological Chemistry, vol. 286, no. 17, pp. 15095-15105, 2011.
69. B. R. Fluharty, E. Biasini, M. Stravalaci et al., "An N-terminal fragment of the prion protein binds to amyloid oligomers and inhibits their neurotoxicity in vivo, " The Journal of Biological Chemistry, vol. 288, no. 11, pp. 7857-7866, 2013.
70. N. D. Younan, C. J. Sarell, P. Davies, D. R. Brown, and J. H. Viles, "The cellular prion protein traps Alzheimer's A in an oligomeric form and disassembles amyloid fibers, " The FASEB Journal, vol. 27, no. 5, pp. 1847-1858, 2013.
71. F. Dohler, D. Sepulveda-Falla, S. Krasemannet al., "Highmolecularmass assemblies of amyloid oligomers bind prion protein in patients with Alzheimer's disease, " Brain, vol. 137, part 3, pp. 873-886, 2014.
72. H. Khosravani, Y. Zhang, S. Tsutsui et al., "Prion protein attenuates excitotoxicity by inhibiting NMDA receptors, " The Journal of Cell Biology, vol. 181, no. 3, pp. 551-565, 2008.
73. A. Santuccione, V. Sytnyk, I. Leshchyns'ka, and M. Schachner, "Prion protein recruits its neuronal receptor NCAM to lipid rafts to activate p59 and to enhance neurite outgrowth, " Journal of Cell Biology, vol. 169, no. 2, pp. 341-354, 2005.
74. S. A. Black, P. K. Stys, G. W. Zamponi, and S. Tsutsui, "Cellular prion protein and NMDA receptor modulation: protecting against excitotoxicity, " Frontiers in Cell and Developmental Biology, vol. 2, article 45, 2014.
75. W. Kudo, H.-P. Lee, W.-Q. Zou et al., "Cellular prion protein is essential for oligomeric amyloid-induced neuronal cell death, " Human Molecular Genetics, vol. 21, no. 5, Article ID ddr542, pp. 1138-1144, 2012.
76. M.-V. Guillot-Sestier, C. Sunyach, S. T. Ferreira et al., " Secretase-derived fragment of cellular prion, N1, protects against monomeric and oligomeric amyloid (A)-associated cell death, "The Journal of Biological Chemistry, vol. 287, no. 7, pp. 5021-5032, 2012.
77. C. Balducci, M. Beeg, M. Stravalaci et al., "Synthetic amyloid oligomers impair long-term memory independently of cellular prion protein, " Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 5, pp. 2295-2300, 2010.
78. A. M. Calella, M. Farinelli, M. Nuvolone et al., "Prion protein andA related synaptic toxicity impairment, "EMBOMolecular Medicine, vol. 2, no. 8, pp. 306-314, 2010.
79. H. W. Kessels, L. N. Nguyen, S. Nabavi, and R. Malinow, "The prion protein as a receptor for amyloid, " Nature, vol. 466, no. 7308, pp. E3-E5, 2010.
80. M. C. Dinamarca, M. Di Luca, J. A. Godoy, and N. C. Inestrosa, "The soluble extracellular fragment of neuroligin-1 targets A oligomers to the postsynaptic region of excitatory synapses, " Biochemical and Biophysical Research Communications, vol. 466, no. 1, pp. 66-71, 2015.
81. M. C. Dinamarca, D. Weinstein, O. Monasterio, and N. C. Inestrosa, "The synaptic protein neuroligin-1 interacts with the amyloid peptide. Is there a role in Alzheimer's disease" Biochemistry, vol. 50, no. 38, pp. 8127-8137, 2011.
82. S. Wright, N. L. Malinin, K. A. Powell, T. Yednock, R. E. Rydel, and I. Griswold-Prenner, "21 and V1 integrin signaling pathways mediate amyloid-induced neurotoxicity, " Neurobiology of Aging, vol. 28, no. 2, pp. 226-237, 2007.
83. K. L. Anderson and A. Ferreira, "1 Integrin activation: A link between amyloid deposition and neuronal death in aging hippocampal neurons, " Journal of Neuroscience Research, vol. 75, no. 5, pp. 688-697, 2004.
84. K. Uemura, A. Kuzuya, N. Aoyagi et al., "Amyloid inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptor, " Neuroscience, vol. 145, no. 1, pp. 5-10, 2007.
85. M. Asada-Utsugi, K. Uemura, Y. Noda et al., "N-cadherin enhances APP dimerization at the extracellular domain and modulates A production, " Journal of Neurochemistry, vol. 119, no. 2, pp. 354-363, 2011.
86. Y. Bai, K. Markham, F. Chen et al., "The in vivo brain interactome of the amyloid precursor protein, " Molecular & Cellular Proteomics, vol. 7, no. 1, pp. 15-34, 2008.
87. K.-P. Chen and F. Dou, "Selective interaction of amyloid precursor protein with different isoforms of neural cell adhesion molecule, " Journal of Molecular Neuroscience, vol. 46, no. 1, pp. 203-209, 2012.
88. Q.-H. Ma, T. Futagawa, W.-L. Yang et al., "A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis, " Nature Cell Biology, vol. 10, no. 3, pp. 283-294, 2008.
89. N. Tachi, Y. Hashimoto, M. Nawa, and M. Matsuoka, "TAG-1 is an inhibitor of TGF2-induced neuronal death via amyloid precursor protein, " Biochemical and Biophysical Research Communications, vol. 394, no. 1, pp. 119-125, 2010.
90. Y. Hashimoto, T. Chiba, M. Yamada et al., "Transforming growth factor beta2 is a neuronal death-inducing ligand for amyloid-beta precursor protein, " Molecular and Cellular Biology, vol. 25, no. 21, pp. 9304-9317, 2005.
91. S. L. Cole and R. Vassar, "The role of amyloid precursor protein processing by BACE1, the secretase, in Alzheimer disease pathophysiology, " The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29621-29625, 2008.
92. J. Majercak, W. J. Ray, A. Espeseth et al., "LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 47, pp. 17967-17972, 2006.
93. E. T. Parkin, N. T. Watt, I. Hussain et al., "Cellular prion protein regulates secretase cleavage of the Alzheimer's amyloid precursor protein, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11062-11067, 2007.
94. H. H. Griffiths, I. J. Whitehouse, H. Baybutt et al., "Prion protein interacts with BACE1 protein and differentially regulates its activity toward wild type and Swedish mutant amyloid precursor protein, "The Journal of Biological Chemistry, vol. 286, no. 38, pp. 33489-33500, 2011.
95. K. Uemura, C. M. Lill, M. Banks et al., "N-cadherin-based adhesion enhances Abeta release and decreases Abeta42/40 ratio, " Journal of Neurochemistry, vol. 108, no. 2, pp. 350-360, 2009.